Literature DB >> 16814378

Association between UHMWPE particle-induced inflammatory osteoclastogenesis and expression of RANKL, VEGF, and Flt-1 in vivo.

Wei Ping Ren1, David C Markel, Renwen Zhang, Xin Peng, Bin Wu, Hawkins Monica, Paul H Wooley.   

Abstract

Wear debris-induced vascularized granulomatous periprosthetic tissue may augment the progress of prosthetic loosening, a major clinical problem after total joint replacement. The purpose of this study is to investigate the association of ultra-high-molecular-weight polyethylene (UHMWPE) particle-induced inflammatory osteoclastogenesis and expression of RANK/RANKL and VEGF/VEGF receptors (Flt-1 and Flk-1) using a mouse osteolysis model. UHMWPE particles were introduced into established air pouches on BALB/c mice, followed by implantation of calvaria bone from syngeneic littermates. Mice were injected with either recombinant VEGF or VEGF inhibitor (VEGF R2/F(c) Chimera). Mice without drug treatment, as well as mice injected with saline alone were included. Each group contains 10 mice. Pouch tissues were harvested 2 weeks after bone implantation for histological and molecular analysis. UHMWPE stimulation significantly increased VEGF gene expression, and exerted a lower enhancement effect on the gene expression of Flt-1 and Flk-1. UHMWPE-stimulated VEGF production was markedly reduced by VEGF inhibitor treatment. Immunofluorescent staining indicated that pouch tissue macrophages were the main source of both VEGF and Flt-1 production. A positive association was observed between tissue inflammation and the levels of VEGF and Flt-1 gene transcripts. Both RANK and RANKL gene transcripts were significantly increased by UHMWPE stimulation, which was subsequently reduced by VEGF inhibitor treatment (p<0.05). VEGF treatment increased TRAP(+) cells in pouches either with or without UHMWPE particle stimulation, and VEGF inhibitor treatment caused a significant reduction in the number of TRAP(+) cells in UHMWPE-containing pouches. This study suggests that VEGF has a role in the regulation of RANK/RANKL-mediated osteoclastogenesis, and warrant future investigations to elucidate the role of VEGF signaling in the pathogenesis of prosthetic loosening.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16814378     DOI: 10.1016/j.biomaterials.2006.04.004

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  22 in total

1.  Elevated cytokine expression of different PEEK wear particles compared to UHMWPE in vivo.

Authors:  V Lorber; A C Paulus; A Buschmann; B Schmitt; T M Grupp; V Jansson; Sandra Utzschneider
Journal:  J Mater Sci Mater Med       Date:  2013-09-26       Impact factor: 3.896

Review 2.  Polyethylene and metal wear particles: characteristics and biological effects.

Authors:  Isabelle Catelas; Markus A Wimmer; Sandra Utzschneider
Journal:  Semin Immunopathol       Date:  2011-01-26       Impact factor: 9.623

Review 3.  Periprosthetic osteolysis: genetics, mechanisms and potential therapeutic interventions.

Authors:  Shahryar Noordin; Bassam Masri
Journal:  Can J Surg       Date:  2012-12       Impact factor: 2.089

4.  Protection against titanium particle-induced inflammatory osteolysis by the proteasome inhibitor bortezomib in vivo.

Authors:  Xin Mao; Xiaoyun Pan; Song Zhao; Xiaochun Peng; Tao Cheng; Xianlong Zhang
Journal:  Inflammation       Date:  2012-08       Impact factor: 4.092

5.  Do tissues from THA revision of highly crosslinked UHMWPE liners contain wear debris and associated inflammation?

Authors:  Ryan M Baxter; Theresa A Freeman; Steven M Kurtz; Marla J Steinbeck
Journal:  Clin Orthop Relat Res       Date:  2011-08       Impact factor: 4.176

6.  Does Suture Type Influence Bacterial Retention and Biofilm Formation After Irrigation in a Mouse Model?

Authors:  David C Markel; Christopher Bergum; Bin Wu; Therese Bou-Akl; Weiping Ren
Journal:  Clin Orthop Relat Res       Date:  2019-01       Impact factor: 4.176

7.  High-density association study of 383 candidate genes for volumetric BMD at the femoral neck and lumbar spine among older men.

Authors:  Laura M Yerges; Lambertus Klei; Jane A Cauley; Kathryn Roeder; Candace M Kammerer; Susan P Moffett; Kristine E Ensrud; Cara S Nestlerode; Lynn M Marshall; Andrew R Hoffman; Cora Lewis; Thomas F Lang; Elizabeth Barrett-Connor; Robert E Ferrell; Eric S Orwoll; Joseph M Zmuda
Journal:  J Bone Miner Res       Date:  2009-12       Impact factor: 6.741

8.  Inhibitory effects of erythromycin on wear debris-induced VEGF/Flt-1 gene production and osteolysis.

Authors:  David C Markel; Renwen Zhang; Tong Shi; Monica Hawkins; Weiping Ren
Journal:  Inflamm Res       Date:  2009-03-05       Impact factor: 4.575

9.  Morphine treatment accelerates sarcoma-induced bone pain, bone loss, and spontaneous fracture in a murine model of bone cancer.

Authors:  Tamara King; Anna Vardanyan; Lisa Majuta; Ohannes Melemedjian; Ray Nagle; Anne E Cress; Todd W Vanderah; Josephine Lai; Frank Porreca
Journal:  Pain       Date:  2007-08-15       Impact factor: 6.961

10.  VEGF165 promotes the osteolytic bone destruction of ewing's sarcoma tumors by upregulating RANKL.

Authors:  Hui Guan; Zhichao Zhou; Ying Cao; Xiaoping Duan; Eugenie S Kleinerman
Journal:  Oncol Res       Date:  2009       Impact factor: 5.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.